[1]
Pandya, J.N. et al. 2026. The Semaglutide Effect: Redefining Treatment Across Diabetes, Obesity, and Cardiometabolic Risk. Indian Journal of Pharmacy & Drug Studies. 5, 3 (Sep. 2026), 119–131.